Skip to main content
Premium Trial:

Request an Annual Quote

A Small Step

GlaxoSmithKline plans to open its labs to outside, nonprofit collaborators to spur research into malaria and other neglected diseases, Chief Executive Andrew Witty told Forbes. One such project for therapies to treat parasitic worms is being carried out in conjunction with Emory University researchers and Alnylam Pharmaceuticals. “GSK is providing us direct access to the scientists and all of the [internal] reports in the program. ... Talking to scientists and finding out what [compounds] are the good ones, that is huge, says Emory’s Dennis Liotta. At the Tree of Life, Jonathan Eisen blogs that “this could be a good first step. But if they really want to advance malaria vaccine research, perhaps they should release their data to everyone?”

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.